Pharmaceuticals (25) | Retention Agreements (25)
Browse by Company
Recent Contracts
-
Retention Agreement, dated as of May 5, 2022, by and between the Registrant and Rahul D. Ballal, Ph.D
(IMARA Inc., Filed With SEC on May 6, 2022)
-
Retention Agreement, dated as of May 5, 2022, by and between the Registrant and Michael P. Gray
(IMARA Inc., Filed With SEC on May 6, 2022)
-
Retention Agreement, dated March 7, 2022, between Michael F. Marino and Optinose US, Inc
(OptiNose, Inc., Filed With SEC on March 8, 2022)
-
Form of Retention Agreement
(Cara Therapeutics, Inc., Filed With SEC on March 1, 2022)
-
Retention Agreement between Endo and Blaise Coleman, dated November 1, 2021
(Endo International plc, Filed With SEC on March 1, 2022)
-
Retention Agreement between Endo and Mark T. Bradley, dated November 1, 2021
(Endo International plc, Filed With SEC on March 1, 2022)
-
Retention Agreement between Endo and Matthew J. Maletta, dated November 1, 2021
(Endo International plc, Filed With SEC on March 1, 2022)
-
Retention Agreement between Endo and Patrick Barry, dated November 1, 2021
(Endo International plc, Filed With SEC on March 1, 2022)
-
Tricida, Inc. Executive Retention Agreement Template Amendment
(Tricida, Inc., Filed With SEC on November 8, 2021)
-
June 21, 2019 Retention Agreement with Douglas Plassche
(ELITE PHARMACEUTICALS INC, Filed With SEC on June 14, 2021)
